Overall Technical outlook

Price Summary

On 2025-12-15, GLENMARK's stock opened at 1975.0, reached a peak of 1990.9, dropped to 1950.8, and ended 0.54% higher at 1985.6, with a volume of 299106 shares.
The highest price the stock achieved in the past 52 weeks is 2226.7, while the lowest price it saw is 0.0.
12 analysts suggest that GLENMARK's future price will lie between 1500.0 and 2735.0, with an average expected price of roughly 2112.0.

Technicals

Support and Resistance: The price for GLENMARK is 1985.6, with support at 1940.9 and resistance at 2042.4. This suggests a range where 1940.9 acts as a base, preventing declines, and 2042.4 caps gains, defining key trading levels.
GLENMARK supportResistance 968435
Support/Resistance for GLENMARK


Aroon: The AROON is showing a neutral stance, not indicating a clear upward or downward trend for Glenmark Pharmaceuticals Limited. This suggests a period of market balance, where neither side is showing dominance.
GLENMARK aroon 968435
Aroon chart for Glenmark Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is in a neutral stance for GLENMARK, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
GLENMARK bbands 968435
Bolinger Bands chart for Glenmark Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bullish, setting a critical support level that may help sustain the market's upward trend. This persistent bullish outlook suggests that the market is likely to continue climbing, with the support level offering a foundation for further growth.
GLENMARK psar 968435
Parabolic Stop and Reverse chart for Glenmark Pharmaceuticals Limited


Stochastic: The stochastic indicator is currently bullish, with the K-line exceeding both the D-line and the 80 level. This configuration indicates robust upward momentum, suggesting that the market may experience further gains. Investors may interpret this as a positive signal for continued upward movement.
GLENMARK stoch 968435
Stochastic chart for Glenmark Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, not indicating a clear upward or downward trend for Glenmark Pharmaceuticals Limited. This suggests a period of market balance, where neither side is showing dominance.
GLENMARK trippleSMA 968435
Tripple SMA chart for Glenmark Pharmaceuticals Limited


A company's technical data, including stock price and trading volume, can provide valuable insights when considered alongside its fundamentals. These include financial performance, market share, and growth strategy, as well as broader industry dynamics. Examining these factors helps investors or analysts make more informed decisions, as the company's fundamentals offer context for understanding how and why certain technical patterns may emerge in the market.